Frequency of anti-infliximab antibodies: patients with RA in routine care – (May 2013) 44352v

04/07/2013

Professor Robert Moots and Dr Steven Young (University of Birmingham School of Immunity and...

Professor Robert Moots and Dr Steven Young (University of Birmingham School of Immunity and Infection), discuss the therapeutic role of antibodies given directly to patients and their response to these antibodies. They review a paper by Krentil et al

Results from the NEIAA Short Report on Ethnicity +1 año 18:43 Wolfgang Schmidt on the use of ultrasound in diagnosing and managing giant cell arteritis (GCA) +1 año 05:47 Dr John Hanly on lupus nephritis +1 año 04:07 RA patient access to DMARDs in Norway +1 año 05:59 Guidance on prescribing drugs in pregnancy and breastfeeding – May 2016 +1 año 05:02 Ver más en APP Comentarios del episodio 4q4s4k